NPY1R and breast cancer: Here we investigate the effect of antagonizing NPY1R and NPY5R isoforms on MAPK signaling, cell migration, cell proliferation and invasion, in 2D and 3D models of hypoxic and normoxic MCF7 and MDA-MB-231 breast cancer cell lines.